Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01074034
Other study ID # G040067
Secondary ID
Status Completed
Phase N/A
First received February 22, 2010
Last updated September 28, 2011
Start date April 2006
Est. completion date June 2011

Study information

Verified date September 2011
Source Boston Scientific Corporation
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

Long term follow-up to monitor safety for patients implanted with a B301 ASSURE device.


Recruitment information / eligibility

Status Completed
Enrollment 157
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient is willing and capable of providing informed consent at an approved clinical investigational center, and able to attend the investigational center as required by the protocol

- Patient is implanted with an investigational B301 device as part of the REASSURE AV study

Exclusion Criteria:

* None

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
B301 ASSURE Device
Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device

Locations

Country Name City State
United States Abington Memorial Hospital Abington Pennsylvania
United States Alaska Heart Institute Anchorage Alaska
United States Piedmont Hospital Atlanta Georgia
United States Boston Medical Center Boston Massachusetts
United States Deborah Heart and Lung Center Browns Mills New Jersey
United States Lahey Clinic Medical Center Burlington Massachusetts
United States Christ Hospital - Cincinnati Cincinnati Ohio
United States The Cleveland Clinic Foundation Cleveland Ohio
United States Ohio State University Medical Center Columbus Ohio
United States Baylor University Medical Center Dallas Texas
United States Mercy Hospital Medical Center Des Moines Iowa
United States Henry Ford Hospital Detroit Michigan
United States Good Samaritan Hospital Downers Grove Illinois
United States Saint Mary's Duluth Clinic Duluth Minnesota
United States Inova Fairfax Hospital Fairfax Virginia
United States St. Mary Medical Center Hobart Indiana
United States Center For Cardiac Arrhythmias Houston Texas
United States Northern California Heart Care Larkspur California
United States Sunrise Hospital & Medical Center Las Vegas Nevada
United States Central Baptist Hospital Lexington Kentucky
United States Louisville Cardiology Medical Group Louisville Kentucky
United States Medical Center Cardiologist Research Louisville Kentucky
United States Heart Care Research Foundation Merrionette Park Illinois
United States Ochsner Foundation Hospital New Orleans Louisiana
United States Mount Sinai Medical Center New York New York
United States Sentara Norfolk General Hospital Norfolk Virginia
United States Orlando Regional Hospital Orlando Florida
United States Owensboro Mercy Health System Owensboro Kentucky
United States Chippenham Medical Center Richmond Virginia
United States St. Joseph Hospital Savannah Georgia
United States Baystate Medical Center Springfield Massachusetts
United States St. Anthony's Medical Center St. Louis Missouri
United States Heart and Vascular Institute St. Petersburg Florida
United States Hillcrest Medical Center Tulsa Oklahoma
United States Reading Hospital and Medical Center West Reading Pennsylvania
United States University of Massachusetts Worcester Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Scientific Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidences of ventricular shock therapy There are no statistical endpoints for this registry. Incidences of ventricular shock therapy and their suspected causes and outcome will be the primary focus of this registry. Report annually Yes
See also
  Status Clinical Trial Phase
Completed NCT03922386 - Safety and Electrical Performances of XFINE Leads N/A
Completed NCT03294018 - Heart Rate Changes Following the Administration of Sugammadex
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT05440071 - PoSt-market Assessment on Safety and Performance of J-sHAPed xFINE Lead
Completed NCT02153242 - The Effects of Selective Site Right Ventricular Pacing
Recruiting NCT01825473 - Study of Erythromycin in GER-Associated Apnea of the Newborn N/A
Completed NCT00950287 - Detection of Neonatal Bradycardia N/A
Completed NCT00721136 - Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation N/A
Completed NCT00286858 - Beluga - Clinical Observations of Automatic Algorithms for Cardiac Pacing
Completed NCT00158925 - The EASYTRAK EPI Clinical Investigation Phase 3
Completed NCT00180557 - Austria Study - Analysis of Difference Between Active and Passive Fixation Leads Phase 4
Completed NCT01076348 - Model 4965 Post-Approval Study
Completed NCT04198220 - BIO|STREAM.ICM Obesity
Recruiting NCT05298748 - The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants N/A
Recruiting NCT04353960 - The Alaska Oculocardiac Reflex Study
Terminated NCT04093414 - Left Bundle Area Versus Selective His Bundle Pacing N/A
Completed NCT03786640 - Abbott Brady 3T MRI PMCF
Recruiting NCT05935007 - Aveir DR Real-World Evidence Post-Approval Study
Recruiting NCT05932602 - AVEIR DR Coverage With Evidence Development (CED) Study
Recruiting NCT04075084 - Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)